Morphologic alterations in esophageal squamous cell carcinoma after preoperative high dose rate intraluminal brachytherapy

Abstract

HDRILBT may cause the keratin gene in the irradiated cells to induce differentiation toward better differentiated cells. Preoperative high dose rate intraluminal brachytherapy may have a role in improving the prognosis of patients with early esophageal cancer treated with a combination of radiotherapy and surgery.